Curium acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy
December 02, 2019 00:00 ET
|
Curium
London and Paris, Dec. 02, 2019 (GLOBE NEWSWIRE) -- — Curium has successfully completed the acquisition of Finnish radiopharmaceuticals company MAP Medical Technologies Oy. The acquisition of MAP...
Curium Announces Plan to Submit an Application to Market Generic Ioflupane I 123 Injection in the U.S.
November 13, 2019 08:00 ET
|
Curium
St. Louis MO, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it intends to submit an abbreviated new drug application for a generic version of DaTscanTM (Ioflupane I 123 Injection) in...
Curium Announces Revised Pricing for Technescan MAG3TM
September 04, 2019 08:30 ET
|
Curium
St. Louis, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it is implementing a new pricing model for Technescan MAG3. Curium is phasing out its pay per dose sales model, in which...
Curium and Progenics Announce European Collaboration for Prostate Cancer Imaging Agent PyL™
January 03, 2019 02:30 ET
|
Curium
Paris, France and St. Louis, MO USA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Curium, a leading global player in Nuclear medicine, and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company...
Curium and RadioMedix Announce Exclusive Global Agreement for 64Cu-Dotatate Development
August 26, 2018 21:00 ET
|
Curium
St. Louis and Houston, Aug. 26, 2018 (GLOBE NEWSWIRE) -- Curium and RadioMedix Inc. announce an exclusive agreement to develop and commercialize 64Cu-Dotatate, an investigational positron emission...
Curium Expands Nuclear Medicine Offerings,Announces U.S. Availability of Xenon Xe 133 Gas
May 10, 2018 07:30 ET
|
Curium
St. Louis Missouri, May 10, 2018 (GLOBE NEWSWIRE) -- Curium, a leading nuclear medicine solutions provider, announced today its re-entry into the radiopharmaceutical Xenon Xe 133 Gas market,...
Curium consolide sa position en France sur le marché TEP avec la finalisation de l’acquisition des activités opérationnelles de CYCLOPHARMA
May 02, 2018 03:10 ET
|
Curium
PARIS, 02 mai 2018 (GLOBE NEWSWIRE) -- Curium a finalisé avec succès l’acquisition des activités opérationnelles de Cyclopharma, laboratoire pharmaceutique développant et produisant des traceurs...
Curium enhances its position in the French PET market with the completion of the acquisition of Cyclopharma’s French commercial and manufacturing operations
May 02, 2018 03:10 ET
|
Curium
Paris, May 02, 2018 (GLOBE NEWSWIRE) -- Curium has successfully completed its previously announced acquisition of the French commercial and manufacturing operations of Cyclopharma, a leading...